Neurocrine Biosciences (NBIX) Raw Materials (2018 - 2025)

Neurocrine Biosciences' Raw Materials history runs 8 years deep, the most recent figure standing at $31.9 million for Q1 2025.

• Quarterly Raw Materials rose 76.24% year-over-year to $31.9 million in Q1 2025, while the trailing twelve-month figure through Mar 2025 was $31.9 million (up 76.24% YoY) and the FY2024 annual result came in at $33.7 million, up 56.74% from the prior year.
• Raw Materials was $31.9 million for Q1 2025 at Neurocrine Biosciences, down from $33.7 million in the prior quarter.
• Across five years, Raw Materials topped out at $33.7 million in Q4 2024 and bottomed at $11.2 million in Q4 2021.
• A 5-year average of $21.7 million and a median of $21.4 million in 2023 frame the typical range for Raw Materials.
• Annual changes were most pronounced in 2021 — Raw Materials plunged 32.53% — and 2023, when it soared 79.17%.
• Neurocrine Biosciences' Raw Materials stood at $11.2 million in 2021, then gained by 7.14% to $12.0 million in 2022, then surged by 79.17% to $21.5 million in 2023, then jumped by 56.74% to $33.7 million in 2024, then declined by 5.34% to $31.9 million in 2025.
• Business Quant data shows NBIX's Raw Materials at $31.9 million in Q1 2025, $33.7 million in Q4 2024, and $23.7 million in Q3 2024.